Clinical Trial Update: A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluated the safety and tolerability of SB-656933-AAA after repeated doses in healthy adult subjects; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SB-656933-AAA

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED